The Journal of Clinical Endocrinology & Metabolism · 2014 · 34 citations · 39 references
MedicineEndocrinologyGeneticsBone MetabolismHuman GeneticsMedical GeneticsBone DisordersBone EndocrinologyBone HealthBone Metabolism DisordersBone Metabolism GeneticsMetabolic Bone DiseaseBone Metabolism Gene VariantsBone Mineral DensityBone Mineral Density GeneticsBone Turnover Markers GeneticsGenetic PolymorphismsSclerostin GeneticsSerum 25-Hydroxyvitamin D StatusSingle-nucleotide Polymorphisms
OBJECTIVE: The aims of this study were as follows: 1) to evaluate the association of serum sclerostin with bone mineral density (BMD) and markers of bone metabolism in postmenopausal Chinese women and 2) to observe the relationships of single-nucleotide polymorphisms (SNPs) within the sclerostin (SOST) gene with serum sclerostin, BMD, and markers of bone metabolism. DESIGN: A cross-sectional study was conducted with 703 postmenopausal Chinese women. Ten tagging SNPs (rs1234612, rs1513670, rs1634330, rs1708635, rs2023794, rs7220711, rs74252774, rs851057, rs851058, and rs865429) of the SOST gene were genotyped. Serum sclerostin and markers of bone metabolism were measured, including serum intact PTH, 25-hydroxyvitamin D [25(OH)D], procollagen type 1 N-terminal propeptide, and β-CrossLaps of type I collagen containing cross-linked C-telopeptide (β-CTX). The BMD of the lumbar spine and proximal femur were measured by dual-energy X-ray absorptiometry. RESULTS: Serum sclerostin was positively correlated with BMD at the lumbar spine, femoral neck, and total hip and with serum 25(OH)D (all P < .01) but negatively correlated with β-CTX (P < .01). The significant relationships between serum sclerostin and BMD and with serum β-CTX persisted, even after adjustments for age, body mass index, and serum 25(OH)D (all P < .01). However, there was no correlation between serum sclerostin and age or serum procollagen type 1 N-terminal propeptide. We failed to identify a significant association between the SNP, haplotypes of SOST and BMD, or serum sclerostin. CONCLUSION: Our results suggested that serum sclerostin was positively correlated with the BMD at the lumbar spine, femoral neck, and total hip and with serum 25(OH)D but was negatively correlated with serum β-CTX. Genetic polymorphisms of SOST may not be a major contributor to variations in the serum sclerostin or BMD in postmenopausal Chinese women.
39
Haploview: analysis and visualization of LD and haplotype maps
Jeffrey C. Barrett, Ben Fry, Julian Maller et al. · Bioinformatics · 2004 · 14.7K citations · Full text
John A. Professor Kanis, L. Joseph Melton, Claus Christiansen et al. · Journal of Bone and Mineral Research · 1994 · 3.9K citations
Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Xiaofeng Li, Heeseog Kang, Wenzhong Liu et al. · Journal of Biological Chemistry · 2005 · 1.4K citations · Full text